SUNSHINE PHARMA 06887Hong Kong Stock Exchange

40.0600.89%( -0.360 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
SUNSHINE PHARMA (06887) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
Sunshine Lake Pharma Co., Ltd.
Market
HKEX Main Board
Listing Date
2025-08-07
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE1000070M8

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)5.65B27/112
Net Profit (Last FY)319.48M34/125
ROE (Last FY)6.27%41/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Zhang Yingjun Executive Director
Jiang Juncai Executive Director
Zhang Zhiyong Executive Director
Zhang Yushuai Non-Executive Director
Tang Xinfa Non-Executive Director
Zhu Yingwei Non-Executive Director
Li Wenjia Non-Executive Director
Li Xintian Independent Non-Executive Director
Ma Dawei Independent Non-Executive Director
Lin Aimei Independent Non-Executive Director
Ye Tao Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-18.

About this page

This page shows SUNSHINE PHARMA (06887) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.